Related Experiment Video

Updated: Mar 23, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

7.1K

Bioinformatic exploration of MTA1-regulated gene networks in colon cancer

Chunxiao Li1, Haijuan Wang1, Feng Lin1

  • 1Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, State Key Laboratory of Molecular Oncology, Beijing, 100021, China.

Frontiers of Medicine
|April 8, 2016
PubMed

Insights

Metastasis-associated gene 1 (MTA1) plays a key role in colon cancer progression. MTA1 is closely linked with AKT1, EP300, and other molecules in Wnt, Notch, and DNA repair pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Metastasis-associated gene 1 (MTA1) is implicated in tumor progression.
  • Understanding the gene regulatory network is crucial for cancer research.
  • The precise role of MTA1 within this network requires further elucidation.

Purpose of the Study:

  • To determine MTA1's position in the global cancer gene regulatory network.
  • To identify genes that cooperate with MTA1 in tumor progression.
  • To explore the biological functions of MTA1 in colon cancer.

Main Methods:

  • Utilized TCGA data sets and the GeneCards database to identify MTA1-related genes.
  • Performed Gene Ontology (GO) and KEGG pathway analyses using DAVID.
  • Conducted gene network analysis with STRING and visualized with Cytoscape.

Main Results:

  • MTA1 is associated with Wnt, Notch, and nucleotide excision repair pathways in colon cancer development.
  • Identified key coregulating molecules including AKT1, EP300, CREBBP, SMARCA4, RHOA, and CAD.
  • Established a close relationship between MTA1 and these molecules in a coregulation process.

Conclusions:

  • MTA1 is a significant factor in colon cancer progression.
  • MTA1's function is intertwined with Wnt, Notch, and DNA repair signaling.
  • Further research into MTA1's role in these pathways is warranted.
Keywords:
bioinformaticscolon cancermetastasis-associated gene 1

More Related Videos

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies07:47

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

2.3K
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

1.1K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K